Related Experiment Video

Updated: Feb 9, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.1K

[IDH1- and IDH2-mutations in brain glial tumors - the new antioncogenic mechanism]

G A Demyashkin1, P V Nikitin2

  • 1Sechenov First Moscow State Medical University, Moscow, Russia; Scientific Clinical Center of Russian Railways, Moscow, Russia.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|June 5, 2018
PubMed

Insights

Mutant isocitrate dehydrogenase 1 (IDH1) gene mutations slow tumor progression and exhibit anti-oncogenic effects. These specific IDH1 mutations represent a novel protective mechanism against brain gliomas.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Mutations in the isocitrate dehydrogenase 1 (IDH1) gene are observed in various cancers.
  • The specific R132H mutation in IDH1 is highly prevalent, occurring in 98.9% of cases.

Purpose of the Study:

  • To investigate the anti-oncogenic effects of IDH1 gene mutations.
  • To elucidate the novel mechanism of intracellular protection mediated by IDH1 mutations in brain gliomas.

Main Methods:

  • Analysis of IDH1 gene mutation patterns.
  • Correlation of mutation status with tumor progression and neoplastic transformation.
  • Investigation of cellular differentiation processes in relation to IDH1 mutations.

Main Results:

  • IDH1 mutations significantly slow tumor progression and reduce the risk of neoplastic transformation.
  • Mutations are highly stereotyped, predominantly occurring as R132H.
  • IDH1 mutations activate a novel anti-oncogene mechanism, blocking differentiation and leading to cerebral hypoplasia in congenital forms.

Conclusions:

  • Stereotyped IDH1 mutations represent a key event in brain gliomas, initiating a cascade of anti-oncogenic mechanisms.
  • IDH1 mutations offer a new perspective on intracellular protection and antitumor strategies.
  • Understanding this mechanism could lead to novel therapeutic approaches for gliomas.
Keywords:
IDH1IDH2astrocytic gliomas

More Related Videos

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures04:01

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

3.0K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

19.3K

Related Concept Videos

Mutations01:39

Mutations

Overview
94.6K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.6K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K
Glial Cells01:04

Glial Cells

Overview
94.2K
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.5K
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
1.2K